These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

872 related articles for article (PubMed ID: 18155113)

  • 1. A comparison of aerobic exercise and resistance training in patients with and without chronic kidney disease.
    Moinuddin I; Leehey DJ
    Adv Chronic Kidney Dis; 2008 Jan; 15(1):83-96. PubMed ID: 18155113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical functioning in end-stage renal disease patients: update 2005.
    Painter P
    Hemodial Int; 2005 Jul; 9(3):218-35. PubMed ID: 16191072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease.
    Chalmers L; Kaskel FJ; Bamgbola O
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):352-64. PubMed ID: 17045221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Physical working capacity and muscle strength in chronic renal failure are improved by exercise].
    Clyne N
    Lakartidningen; 2004 Dec; 101(50):4111-5. PubMed ID: 15631266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise training and reduction of cardiovascular disease risk factors in patients with chronic kidney disease.
    Bronas UG
    Adv Chronic Kidney Dis; 2009 Nov; 16(6):449-58. PubMed ID: 19801135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advanced chronic kidney disease].
    Alcázar Arroyo R; Orte Martínez L; Otero González A
    Nefrologia; 2008; 28 Suppl 3():3-6. PubMed ID: 19018731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of dynamic strength training on insulin sensitivity in men with insulin resistance].
    Hejnová J; Majercík M; Polák J; Richterová B; Crampes F; deGlisezinski I; Stich V
    Cas Lek Cesk; 2004; 143(11):762-5. PubMed ID: 15628572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Principles of exercising in patients with chronic kidney disease, on dialysis and for kidney transplant recipients.
    Fuhrmann I; Krause R
    Clin Nephrol; 2004 May; 61 Suppl 1():S14-25. PubMed ID: 15233243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance training for chronic heart failure patients on beta blocker medications.
    Levinger I; Bronks R; Cody DV; Linton I; Davie A
    Int J Cardiol; 2005 Jul; 102(3):493-9. PubMed ID: 16004896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiorenal syndrome].
    Portolés Pérez J; Cuevas Bou X
    Nefrologia; 2008; 28 Suppl 3():29-32. PubMed ID: 19018735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease.
    Kendrick J; Chonchol MB
    Nat Clin Pract Nephrol; 2008 Dec; 4(12):672-81. PubMed ID: 18825155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial dysfunction and chronic kidney disease: treatment options.
    Wu-Wong JR
    Curr Opin Investig Drugs; 2008 Sep; 9(9):970-82. PubMed ID: 18729004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress, inflammation and cardiovascular disease in chronic renal failure.
    Cottone S; Lorito MC; Riccobene R; Nardi E; Mulè G; Buscemi S; Geraci C; Guarneri M; Arsena R; Cerasola G
    J Nephrol; 2008; 21(2):175-9. PubMed ID: 18446711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential role of growth factors with particular focus on growth hormone and insulin-like growth factor-1 in the management of chronic kidney disease.
    Feldt-Rasmussen B; El Nahas M
    Semin Nephrol; 2009 Jan; 29(1):50-8. PubMed ID: 19121474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protecting the endothelium: a new focus for management of chronic kidney disease.
    Diaz-Buxo JA; Woods HF
    Hemodial Int; 2006 Jan; 10(1):42-8. PubMed ID: 16441826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of effect of IGF-I on the glomerular filtration rate in non-diabetic patients with advanced chronic kidney disease.
    Kuan Y; Surman J; Frystyk J; El Nahas AM; Flyvbjerg A; Haylor JL
    Growth Horm IGF Res; 2009 Jun; 19(3):219-25. PubMed ID: 19046909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The endothelin system and its antagonism in chronic kidney disease.
    Dhaun N; Goddard J; Webb DJ
    J Am Soc Nephrol; 2006 Apr; 17(4):943-55. PubMed ID: 16540557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress in uremia: the role of anemia correction.
    Lahera V; Goicoechea M; de Vinuesa SG; Oubiña P; Cachofeiro V; Gómez-Campderá F; Amann R; Luño J
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S174-7. PubMed ID: 17130258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.